CIP2A-BP can directly bind the tumor oncogene CIP2A to replace the B56γ subunit of PP2A, thereby inhibiting the invasion and metastasis of triple-negative breast cancer [5]. The gene discussed is LINC00665; the disease is triple-negative breast carcinoma.